Treasurer of the State of North Carolina’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.5M Buy
120,134
+1,759
+1% +$783K 0.17% 102
2025
Q1
$57.4M Buy
118,375
+1,582
+1% +$767K 0.23% 83
2024
Q4
$47M Buy
116,793
+520
+0.4% +$209K 0.18% 94
2024
Q3
$54.1M Sell
116,273
-15,646
-12% -$7.28M 0.22% 83
2024
Q2
$61.8M Buy
131,919
+1,180
+0.9% +$553K 0.26% 65
2024
Q1
$54.7M Sell
130,739
-867
-0.7% -$362K 0.24% 81
2023
Q4
$53.5M Sell
131,606
-717
-0.5% -$292K 0.26% 76
2023
Q3
$46M Sell
132,323
-715
-0.5% -$249K 0.25% 79
2023
Q2
$46.8M Sell
133,038
-62
-0% -$21.8K 0.25% 80
2023
Q1
$41.9M Buy
133,100
+1,535
+1% +$484K 0.24% 87
2022
Q4
$38M Buy
131,565
+5,844
+5% +$1.69M 0.23% 93
2022
Q3
$36.4M Buy
125,721
+549
+0.4% +$159K 0.24% 80
2022
Q2
$35.3M Buy
125,172
+7,597
+6% +$2.14M 0.22% 88
2022
Q1
$30.7M Buy
117,575
+2,691
+2% +$702K 0.17% 118
2021
Q4
$25.2M Buy
114,884
+1,673
+1% +$367K 0.13% 151
2021
Q3
$20.5M Buy
113,211
+310
+0.3% +$56.2K 0.12% 162
2021
Q2
$22.8M Sell
112,901
-950
-0.8% -$192K 0.13% 157
2021
Q1
$24.5M Buy
113,851
+400
+0.4% +$86K 0.15% 134
2020
Q4
$26.8M Buy
113,451
+510
+0.5% +$121K 0.18% 122
2020
Q3
$30.7M Buy
112,941
+430
+0.4% +$117K 0.23% 83
2020
Q2
$32.7M Sell
112,511
-12,450
-10% -$3.61M 0.27% 73
2020
Q1
$29.7M Buy
124,961
+10,400
+9% +$2.47M 0.26% 81
2019
Q4
$25.1M Buy
114,561
+1,160
+1% +$254K 0.21% 114
2019
Q3
$19.2M Sell
113,401
-47,070
-29% -$7.97M 0.17% 140
2019
Q2
$29.4M Buy
160,471
+48
+0% +$8.8K 0.18% 128
2019
Q1
$29.5M Buy
160,423
+2,509
+2% +$462K 0.19% 117
2018
Q4
$26.2M Buy
157,914
+79
+0.1% +$13.1K 0.19% 119
2018
Q3
$30.4M Buy
157,835
+52,818
+50% +$10.2M 0.19% 115
2018
Q2
$17.8M Buy
105,017
+66,031
+169% +$11.2M 0.18% 129
2018
Q1
$6.35M Buy
+38,986
New +$6.35M 0.17% 134